back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-19 08:21 Tx date 2024-04-18 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+4,000 vol $0.40 each |
599,400 | |
| Filed 2024-04-17 09:39 Tx date 2024-04-17 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+44,000 vol $0.375 each |
85,000 | |
| Filed 2024-04-17 09:38 Tx date 2024-04-16 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,788
-22,000 vol $0.354 each |
41,000 | |
| Filed 2024-04-12 21:59 Tx date 2024-04-12 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,760
+6,000 vol $0.46 each |
595,400 | |
| Filed 2024-03-22 16:15 Tx date 2024-03-22 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,142
+13,500 vol $0.455 each |
63,000 | |
| Filed 2024-03-19 09:34 Tx date 2024-03-18 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,960
+14,500 vol $0.48 each |
49,500 | |
| Filed 2024-03-15 16:36 Tx date 2024-03-15 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,076
+16,826 vol $0.48 each |
50,000 | |
| Filed 2024-03-15 12:28 Tx date 2024-03-15 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,800
+10,000 vol $0.48 each |
35,000 | |
| Filed 2024-03-15 11:05 Tx date 2024-03-14 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,882
+3,900 vol $0.4826 each |
589,400 | |
| Filed 2024-03-08 20:19 Tx date 2024-03-07 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,494
+3,000 vol $0.4983 each |
585,500 | |
| Filed 2024-02-16 12:29 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Holder: 2253549 Ontario Ltd (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2024-02-16 12:28 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2024-02-16 00:07 Tx date 2024-02-15 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,915
+31,500 vol $0.41 each |
74,595 | |
| Filed 2024-02-16 00:05 Tx date 2024-02-09 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
99 - Correction of information
|
$12,125
+25,000 vol $0.485 each |
25,000 | |
| Filed 2024-02-16 00:02 Tx date 2022-02-01 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-16 00:01 Tx date 2024-02-09 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+25,000 vol $0.50 each |
43,095 | |
| Filed 2024-02-09 16:47 Tx date 2024-02-09 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,825
+50,000 vol $0.4965 each |
||
| Filed 2024-02-14 08:44 Tx date 2024-02-13 |
$CIII
Cytophage Technologies Ltd. |
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+5,000 vol $0.50 each |
5,000 | |
| Filed 2024-02-14 08:42 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-14 08:41 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-14 08:06 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-12 17:15 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
650,000 | ||
| Filed 2024-02-12 17:13 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
5,000,000 | ||
| Filed 2024-02-12 17:11 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Gabor, Robert Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2024-02-12 17:10 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Gabor, Robert Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-02-12 17:08 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kodihalli, Shanthamma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2024-02-12 17:06 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kodihalli, Shanthamma
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2024-02-12 17:04 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kodihalli, Shanthamma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2024-02-12 17:00 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Medwick, Heather Katherine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2024-02-12 16:58 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Medwick, Heather Katherine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
| Filed 2024-02-12 16:56 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Hurley, Charles
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2024-02-09 16:47 Tx date 2024-02-09 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,825
+50,000 vol $0.4965 each |
68,095 | |
| Filed 2024-02-06 17:51 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: Chunkerhead Ltd. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+760,000 vol |
868,570 | |
| Filed 2024-02-06 17:49 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+152,500 vol |
273,133 | |
| Filed 2024-02-06 17:20 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-531,114 vol |
236,441 | |
| Filed 2024-02-06 17:20 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-212,445 vol |
767,555 | |
| Filed 2024-02-06 17:18 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-531,114 vol |
||
| Filed 2024-02-06 17:15 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-212,445 vol |
||
| Filed 2024-02-06 17:04 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-104,326 vol |
33,174 | |
| Filed 2024-02-06 17:01 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-379,367 vol |
120,633 | |
| Filed 2024-02-06 16:59 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: Chunkerhead Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-341,430 vol |
108,570 | |
| Filed 2024-02-06 16:57 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-56,905 vol |
18,095 | |
| Filed 2024-02-06 15:29 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Holder: 2253549 Ontario Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2024-02-06 15:20 Tx date 2024-02-02 |
$CIII
Cuspis Capital III Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2024-02-06 15:19 Tx date 2024-02-02 |
$CIII
Cuspis Capital III Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2024-02-06 10:05 Tx date 2024-02-02 |
$CIII
Cuspis Capital III Ltd. |
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2023-05-15 16:09 Tx date 2023-05-15 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+50,000 vol $0.13 each |
137,500 | |
| Filed 2023-02-24 13:56 Tx date 2023-02-22 |
$CIII
Cuspis Capital III Ltd. |
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+55,000 vol |
755,000 | |
| Filed 2023-02-16 11:29 Tx date 2023-02-14 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,937
+87,500 vol $0.125 each |
862,500 | |
| Filed 2023-02-14 18:18 Tx date 2023-02-14 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,937
+87,500 vol $0.125 each |
87,500 | |
| Filed 2022-07-15 15:43 Tx date 2022-07-15 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+50,000 vol $0.13 each |
775,000 | |
| Filed 2022-07-15 12:50 Tx date 2022-07-15 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+50,000 vol $0.13 each |
75,000 | |
| Filed 2022-07-11 20:03 Tx date 2022-07-11 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+25,000 vol $0.14 each |
25,000 | |
| Filed 2022-07-11 20:00 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-11 19:59 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-11 18:58 Tx date 2022-07-11 |
$CIII
Cuspis Capital III Ltd. |
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+75,000 vol $0.14 each |
700,000 | |
| Filed 2022-07-11 13:37 Tx date 2022-07-11 |
$CIII
Cuspis Capital III Ltd. |
Schoevest Investment Inc.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+50,000 vol $0.14 each |
950,000 | |
| Filed 2022-06-22 09:23 Tx date 2022-06-21 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,000
+100,000 vol $0.14 each |
725,000 | |
| Filed 2022-02-07 17:35 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
840,000 | |
| Filed 2022-02-07 17:21 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+240,000 vol |
240,000 | |
| Filed 2022-02-07 17:19 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-07 17:15 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
625,000 | ||
| Filed 2022-02-04 12:05 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
840,000 | ||
| Filed 2022-02-04 12:02 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
625,000 | ||
| Filed 2022-02-03 15:03 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Schoenmakers, Jack Theodorus
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
840,000 | |
| Filed 2022-02-03 15:02 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Schoenmakers, Jack Theodorus
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+240,000 vol |
240,000 | |
| Filed 2022-02-03 14:51 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Schoenmakers, Jack Theodorus
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-03 14:42 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Schoevest Investment Inc.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
900,000 | ||
| Filed 2022-02-03 14:25 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
980,000 | |
| Filed 2022-02-03 14:23 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+280,000 vol |
280,000 | |
| Filed 2022-02-03 14:16 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-03 11:33 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2022-02-03 11:32 Tx date 2022-02-01 |
$CIII
Cuspis Capital III Ltd. |
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Chunkerhead Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
450,000 |